全文获取类型
收费全文 | 8179篇 |
免费 | 591篇 |
国内免费 | 55篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 176篇 |
妇产科学 | 168篇 |
基础医学 | 1388篇 |
口腔科学 | 196篇 |
临床医学 | 810篇 |
内科学 | 1815篇 |
皮肤病学 | 234篇 |
神经病学 | 944篇 |
特种医学 | 217篇 |
外科学 | 831篇 |
综合类 | 25篇 |
一般理论 | 5篇 |
预防医学 | 548篇 |
眼科学 | 113篇 |
药学 | 618篇 |
中国医学 | 10篇 |
肿瘤学 | 691篇 |
出版年
2024年 | 18篇 |
2023年 | 130篇 |
2022年 | 236篇 |
2021年 | 396篇 |
2020年 | 250篇 |
2019年 | 296篇 |
2018年 | 296篇 |
2017年 | 249篇 |
2016年 | 267篇 |
2015年 | 267篇 |
2014年 | 382篇 |
2013年 | 440篇 |
2012年 | 686篇 |
2011年 | 614篇 |
2010年 | 363篇 |
2009年 | 344篇 |
2008年 | 528篇 |
2007年 | 484篇 |
2006年 | 484篇 |
2005年 | 463篇 |
2004年 | 391篇 |
2003年 | 363篇 |
2002年 | 318篇 |
2001年 | 68篇 |
2000年 | 47篇 |
1999年 | 58篇 |
1998年 | 66篇 |
1997年 | 52篇 |
1996年 | 35篇 |
1995年 | 38篇 |
1994年 | 23篇 |
1993年 | 17篇 |
1992年 | 24篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 10篇 |
1988年 | 16篇 |
1987年 | 10篇 |
1986年 | 7篇 |
1985年 | 13篇 |
1984年 | 4篇 |
1983年 | 3篇 |
1981年 | 5篇 |
1977年 | 4篇 |
1967年 | 2篇 |
1907年 | 2篇 |
1906年 | 3篇 |
1905年 | 3篇 |
1904年 | 2篇 |
1903年 | 4篇 |
排序方式: 共有8825条查询结果,搜索用时 15 毫秒
171.
Susan Mikkelsen Khoa Manh Dinh Jens Kjrgaard Boldsen Ole Birger Pedersen Gitte Juel Holst Mikkel Steen Petersen Kathrine Agergrd Kaspersen Bjarne Kuno Mller Kaspar Rene Nielsen Helene Martina Paarup Klaus Rostgaard Henrik Hjalgrim Erik Srensen Linda Jenny Handgaard Thomas Folkmann Hansen Karina Banasik Kristoffer Slvsten Burgdorf Henrik Ullum Torben Sigsgaard Christian Erikstrup 《Clinical and translational allergy》2021,11(1)
BackgroundAllergic rhinitis (AR), allergic conjunctivitis (AC), and asthma composing multiple phenotypes and improved understanding of these phenotypes and their respective risk factors are needed.ObjectivesThe objective of this study was to define the prevalence of AR, AC, and asthma and their association with allergen‐specific immunoglobulin E (sIgE) sensitization in a large cohort of blood donors and identify risk factors.MethodsFrom the nationwide population‐based Danish Blood Donor Study, 52,976 participants completed an electronic questionnaire including AR, AC, asthma, allergic predisposition, and childhood residence. Of these, 25,257 were additionally tested for sIgE to inhalation allergens (Phadiatop).ResultsThe prevalence of sIgE sensitization, AR, AC, and asthma was 30%, 19%, 15%, and 9%, respectively. The youngest birth cohorts had the highest prevalence of sIgE sensitization and symptoms of asthma, AR, and AC, and for asthma, they apparently experienced symptoms at an earlier age. The sIgE sensitization was positively associated with male sex. The sIgE seroprevalence was higher in participants with both AR and AC (ARC) than in participants with either AR or AC. Allergic predisposition and sIgE sensitization increased the risk of the diseases, while farm upbringing was associated with reduced prevalence of ARC, however, only in sIgE sensitized participants.ConclusionBirth year, childhood residence, sIgE sensitization, and allergic predisposition were associated with asthma, AR, and AC prevalence. Individuals with self‐reported ARC represent a primarily sIgE‐positive phenotype, while those with either AR or AC represent more diverse phenotypes. 相似文献
172.
173.
174.
175.
176.
177.
178.
Surgical complications after kidney transplantation: different impacts of immunosuppression,graft function,patient variables,and surgical performance 下载免费PDF全文
Martina Koch Alexandros Kantas Katja Ramcke Anna I. Drabik Björn Nashan 《Clinical transplantation》2015,29(3):252-260
The population of kidney transplant (KTx) recipients often has complex medical and immunological conditions. Surgical complications (SCs) contribute to the increasing morbidity and costs in these patients. We analyzed the risk factors for SC in 405 KTx patients treated using defined immunosuppressive regimens according to their clinical and immunological risk profile: (1) standard immunosuppression (SIS) with IL‐2 receptor mAb, CNI, and (a) mycophenolic acid (MPA) or (b) mTOR inhibitor; and (2) more intense immunosuppression (IIS) with (a) ATG or (b) the additional use of plasma exchange and B‐ and T‐cell‐depleting agents. In a mixed effects logistic regression model, we identified the following risk factors for SC: male gender, diabetes, and post‐operative dialysis. No difference was found between the patients who received SIS with MPA and those who received mTOR inhibitors. The risk of suffering complications with IIS increases with age. In addition to IIS, diabetes was a risk for wound healing disorders. Therapeutic anticoagulation and a third or subsequent retransplantation increased the rate of bleeding. We did not identify immunosuppression or patient demographics as risk factors for lymphoceles or ureter complications; however, we demonstrated that the surgeon had a significant impact on severe complications, especially those of the ureter. 相似文献
179.
Martina Koch Thorsten Wiech Matthias Marget Sven Peine Hansjrg Thude Eike G. Achilles Lutz Fischer Anja Lehnhardt Friedrich Thaiss Bjoern Nashan 《Clinical transplantation》2015,29(11):1021-1028
ABO‐incompatible (ABOi) kidney transplantation (KTx) has become an accepted therapeutic option in renal replacement therapy for patients without a blood group‐compatible living donor. Using different desensitization strategies, most centers apply B‐cell depletion with rituximab and maintenance immunosuppression (IS) with tacrolimus and mycophenolic acid. This high load of total IS leads to an increased rate of surgical complications and virus infections in ABOi patients. Our aim was to establish ABOi KTx using an immunosuppressive regimen, which is effective in preventing acute rejection without increasing the risk for viral infections. Therefore, we selected a de novo immunosuppressive protocol with low‐dose calcineurin inhibitor and the mTOR inhibitor everolimus for our ABOi program. Here, we report the first 25 patients with a complete three‐yr follow‐up treated with this regimen. Three‐yr patient survival and graft survival were 96% and 83%. The rate of acute T‐cell‐mediated rejections was low (12%). Cytomegalovirus (CMV) infection was evident in one patient only (4%). Surgical complications were common (40%), but mild in 80% of cases. We demonstrate that ABOi KTx with a de novo mTOR inhibitor‐based regimen is feasible without severe surgical or immunological complications and a low rate of viral infections. 相似文献
180.